Cobra has been a manufacturer of GMP viral vector products for gene therapies and viral vaccines since 2002 and more recently immuno-oncology therapies.
Our team provides GMP manufacture of viral vector products following Good Manufacturing Practices of production and testing for all viral manufacturing programs to ensure quality products for our customers’ preclinical and clinical trials through to commercial supply.
Processes are clearly defined, controlled and can be qualified to ensure compliance, clear records are made, and any deviations are investigated and documented. We are able to provide a certificate of GMP compliance and, if required, a GMP campaign summary report plus QA review of completed documentation.
